全文获取类型
收费全文 | 53764篇 |
免费 | 3106篇 |
国内免费 | 938篇 |
专业分类
耳鼻咽喉 | 303篇 |
儿科学 | 593篇 |
妇产科学 | 563篇 |
基础医学 | 5094篇 |
口腔科学 | 1095篇 |
临床医学 | 6201篇 |
内科学 | 5664篇 |
皮肤病学 | 960篇 |
神经病学 | 2229篇 |
特种医学 | 1321篇 |
外国民族医学 | 5篇 |
外科学 | 5004篇 |
综合类 | 7658篇 |
现状与发展 | 3篇 |
预防医学 | 5555篇 |
眼科学 | 404篇 |
药学 | 8280篇 |
6篇 | |
中国医学 | 2915篇 |
肿瘤学 | 3955篇 |
出版年
2023年 | 593篇 |
2022年 | 1195篇 |
2021年 | 1733篇 |
2020年 | 1351篇 |
2019年 | 3999篇 |
2018年 | 3654篇 |
2017年 | 2120篇 |
2016年 | 1341篇 |
2015年 | 1636篇 |
2014年 | 3814篇 |
2013年 | 3289篇 |
2012年 | 2676篇 |
2011年 | 2925篇 |
2010年 | 2684篇 |
2009年 | 3217篇 |
2008年 | 2278篇 |
2007年 | 3108篇 |
2006年 | 2709篇 |
2005年 | 2092篇 |
2004年 | 1129篇 |
2003年 | 1200篇 |
2002年 | 939篇 |
2001年 | 787篇 |
2000年 | 668篇 |
1999年 | 524篇 |
1998年 | 459篇 |
1997年 | 394篇 |
1996年 | 384篇 |
1995年 | 355篇 |
1994年 | 323篇 |
1993年 | 231篇 |
1992年 | 232篇 |
1991年 | 213篇 |
1990年 | 160篇 |
1989年 | 149篇 |
1988年 | 119篇 |
1987年 | 158篇 |
1986年 | 146篇 |
1985年 | 445篇 |
1984年 | 481篇 |
1983年 | 332篇 |
1982年 | 325篇 |
1981年 | 256篇 |
1980年 | 259篇 |
1979年 | 172篇 |
1978年 | 95篇 |
1977年 | 99篇 |
1976年 | 84篇 |
1975年 | 70篇 |
1974年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
目的 评价美国国家电器制造协会(National Electrical Manufactures Association, NEMA)最新标准(NU 2-2018)在正电子发射型计算机断层显像/电子计算机断层显像(positron emission tomography/computed tomography, PET/CT)设备性能检测中的作用。 方法 依据最新的NEMA NU 2-2018标准,检测西门子Biograph Vision PET/CT的空间分辨率、灵敏度、散射分数、计数丢失、随机符合、飞行时间分辨率、计数丢失率和随机符合校正精度、图像质量、衰减和散射校正精度及PET与CT配准精度指标。 结果 距视野中心1 cm处横向和轴向空间分辨率分别为3.75 mm和3.76 mm;在视野中心和轴向10 cm处的灵敏度分别为16.83 kcps/MBq和16.67 kcps/MBq;放射性浓度为27.37 kBq/mL时,最大等效噪声计数率为258.26 kcps,散射分数为38.58%;系统时间分辨率为209.82 ps;图像质量模型的对比度恢复系数范围为88.9%~96.2%,背景变异系数范围为2.05%~6.80%,平均肺插件残余误差为2.43%;计数丢失和随机符合校正最大误差为3.9%;距离床板末端 5 cm 和 100 cm处,在距视野中心Y轴1 cm处,PET和CT的配准精度分别为0.46 mm和1.07 mm,在距视野中心X轴20 cm处,PET和CT的配准精度分别为1.06 mm和1.45 mm,在距视野中心Y轴20 cm处PET和CT的配准精度分别为0.85 mm和1.15 mm。 结论 NEMA NU 2-2018标准检测条件更加接近临床,能更好地反映PET/CT设备的系统性能。 相似文献
3.
《Cancer radiothérapie》2022,26(4):547-556
PurposeSurface-guided radiotherapy is useful for the pre-positioning and monitoring of radiotherapy. The purpose of this study was to investigate the impact of surface guidance on the repeatability of patient localization and to estimate the specific point at which high positional errors occur.Materials and methodsTen patients without the VOXELAN system (non-VXLN group) and 10 patients with the VOXELAN as the pre-positioning procedure (VXLN group) were included in this analysis. Twelve regions of interest (ROI) were defined in all the patients to verify any misalignment during radiotherapy. Thirteen ROIs were defined on the isocenter.ResultsCompared with the non-VXLN group, the translational positional errors of the VXLN group were the same for all the ROIs. The mean translational positional errors of the VXLN group in the longitudinal direction were approximately 0.1 mm, and the standard deviation was the largest among the three directions in all the ROIs. The magnitude of the standard deviation in the non-VXLN group varied independently of the ROI and direction. The standard deviations of the VXLN group in the longitudinal direction were large in all the ROIs, while the standard deviations in the vertical and lateral directions were small.ConclusionPre-positioning with a surface guidance system reduced the body twist and rotation, which could not be corrected by image-guided radiotherapy alone. Since the VOXELAN can detect positioning errors quickly and without additional radiation exposure to the patient, it can be used as a tool for pre-positioning in radiotherapy. 相似文献
4.
5.
6.
PurposeOptical coherence tomography angiography (OCTA) was utilized to examine changes in ocular surface squamous neoplasia (OSSN) vascular patterns over time in individuals treated with topical medical therapy.MethodsTen individuals with OSSN diagnosed by clinical examination and high resolution (HR)-optical coherence tomography (OCT) were recruited. All individuals received topical immuno- or chemotherapy. OCTA images were obtained and analyzed at three points: presentation, mid-treatment and tumor resolution. Tumor metrics including tumor area (TA), tumor volume (TV), tumor depth (TD), and total tumor density (TTD) were calculated. Vessel area density (VAD) was also quantified within the OSSN, the subepithelium under and adjacent to the OSSN and the subepithelium of the uninvolved, contralateral eye. Vascular network changes were also subjectively evaluated.ResultsTA, TV, TD and TTD all significantly decreased with time (p < 0.001). The mean VAD within the OSSN significantly decreased (p < 0.001) between visits (presentation: 26.52 ± 6.8%, mid-treatment: 7.19 ± 5.88%, tumor resolution: 0.11 ± 0.34%). The mean subepithelial VAD under the OSSN also decreased with time (23.22 ± 11.03%, 20.99 ± 5.99% and 19.58 ± 7.08%), and after resolution the sub-tumor VAD (19.58 ± 7.08%) was comparable to the subepithelial VAD in the contralateral eye (15.47 ± 4.37%, p > 0.05). The mean VAD in the subepithelium adjacent to the OSSN increased with treatment, then decreased significantly between mid-treatment and resolution (23.26 ± 4.54, 28.30 ± 7.43% and 21.68 ± 6.10%, p = 0.009). Qualitatively, the tumor subepithelial vascular network was complex and dense but with tumor resolution appeared less tortuous and similar to the uninvolved eye.ConclusionOCTA provided insight into the pathophysiology of tumor angiogenesis, showing decreased vascular density and normalization of vascular networks associated with tumor resolution. 相似文献
7.
《Radiography》2022,28(2):454-459
IntroductionMR facilities must implement and maintain adequate screening and safety procedures to ensure safety during MR examinations. The aim of this study was to evaluate a multi-step MR safety screening process used at a 7T facility regarding incidence of different types of safety risks detected during the safety procedure.MethodsSubjects scheduled for an MR examination and having entered the 7T facility during 2016–2019 underwent a pre-defined multi-step MR safety screening process. Screening documentation of 1819 included subjects was reviewed, and risks identified during the different screening steps were compiled. These data were also related to documented decisions made by a 7T MR safety committee and reported MR safety incidents.ResultsPassive or active implants (n = 315) were identified in a screening form and/or an additional documented interview in 305 subjects. Additional information not previously self-reported by the subject, regarding implants necessitating safety decisions performed by the staff was revealed in the documented interview in 102 subjects (106 items). In total, the 7T MR safety committee documented a decision in 36 (2%) of the included subjects. All of these subjects were finally cleared for scanning.ConclusionA multi-step screening process allows a thorough MR screening of subjects, avoiding safety incidents. Different steps in the process allow awareness to rise and items to be detected that were missed in earlier steps.Implications for practiceSafety questions posed at a single timepoint during an MR screening process might not reveal all safety risks. Repetition and rephrasing of screening questions leads to increased detection of safety risks. This could be effectively mitigated by a multi-step screening process. A multi-disciplinary safety committee is efficient at short notice responding to unexpected safety issues. 相似文献
8.
9.
10.
目的探讨ω-3多不饱和脂肪酸(ω-3 poly unsaturated fatty acids,ω-3 PUFAs)对慢性移植物抗宿主病(chronic graft versus host disease,cGVH)狼疮模型小鼠的免疫调节功能影响。方法单次腹腔注射bm12小鼠淋巴细胞建立cGVH小鼠模型,造模当天分别给予90%ω-3 PUFAs和97%EPA灌胃治疗,持续14 d。通过流式细胞术检测小鼠脾脏淋巴细胞中各免疫指标,ELISA检测小鼠血清中总IgG水平。结果与正常对照组相比,cGVH组明显下调Treg亚群,明显上调TFH细胞、生发中心B细胞和浆细胞亚群;与模型对照组相比,90%ω-3和97%EPA均明显上调Treg亚群,并明显下调TFH细胞、生发中心B细胞和浆细胞亚群;且97%EPA组小鼠血清中总IgG水平明显下降。结论在cGVH狼疮小鼠模型中,ω-3 PUFAs通过增加Treg细胞,减少TFH细胞、生发中心B细胞和浆细胞,抑制IgG的分泌,从而发挥免疫抑制作用,且其免疫抑制作用可能与ω-3 PUFAs含量相关。 相似文献